Literature DB >> 3008738

Rat atrial natriuretic factor suppresses proopiomelanocortin-derived peptides secretion from both anterior and intermediate lobe cells and growth hormone release from anterior lobe cells of rat pituitary in vitro.

T Shibasaki, M Naruse, N Yamauchi, A Masuda, T Imaki, K Naruse, H Demura, N Ling, T Inagami, K Shizume.   

Abstract

Synthetic rat atrial natriuretic factor (ANF) was found to attenuate, in a dose-dependent manner, basal and corticotropin-releasing factor-induced secretion of proopiomelanocortin-derived peptides from cultured anterior and intermediate lobe cells of rat pituitary. ANF was also found to suppress basal and growth hormone-releasing factor-stimulated secretion of growth hormone from anterior lobe cells of rat pituitary. These results, together with reports of the existence of ANF-positive neurons in the hypothalamus and ANF-positive fibers in the median eminence, suggest that hypothalamic ANF is probably involved in the regulation of pituitary hormone secretion, especially that of proopiomelanocortin-derived peptides and growth hormone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008738     DOI: 10.1016/0006-291x(86)91032-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

3.  Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; M Apostolakis; S Bountzioukas; O Guiba-Tziampiri; H Kontoleon-Vakalopoulou; K Mavroudis
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

4.  Atrial natriuretic factor in patients with acromegaly.

Authors:  G Deray; P Chanson; G Maistre; A Warnet; J Eurin; C Barthelemy; F Masson; F Martinez; J Lubetzki; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Effect of human atrial natriuretic peptide on blood glucose concentrations and hormone stimulation during insulin-induced hypoglycaemia in healthy man.

Authors:  E Jungmann; C Konzok; E Höll; W Fassbinder; K Schöffling
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone.

Authors:  C R Franci; J A Anselmo-Franci; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 7.  Atrial natriuretic peptide in the central nervous system of the rat.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

Review 8.  60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides.

Authors:  Niamh X Cawley; Zhaojin Li; Y Peng Loh
Journal:  J Mol Endocrinol       Date:  2016-02-15       Impact factor: 5.098

9.  Localization of binding sites for atrial natriuretic factor and angiotensin II in the central nervous system of the clawed toad Xenopus laevis.

Authors:  W Kloas; W Hanke
Journal:  Cell Tissue Res       Date:  1992-02       Impact factor: 5.249

Review 10.  Discovery of atrial natriuretic factor in the brain: its characterization and cardiovascular implication.

Authors:  T Inagami; I Tanaka; J C McKenzie; M Nakamaru; R Takayanagi; T Imada; R Pochet; A Resibois; M Naruse; K Naruse
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.